STAT3 mediates Nilotinib response in KIT-altered Melanoma: a Phase II Multicenter Trial of the French Skin Cancer Network.
| Image |  |
|---|---|
| Description | scientific article published on 23 August 2017 |
| Author/s |
author: Celeste Lebbe Julie Delyon Maxime Battistella Stéphane Dalle Nicolas Meyer Sylvie Chevret |
| Publication date | August 24, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |